Vision and trajectory

At Orient we have more than 90 years of passion and dedication for the textile sector, which has driven us to evolve proactively. We invest in the new uses and applications demanded by a constantly evolving market.
Our potential is based on 3 pillars: advanced technology, high quality, and personalized service. To this end, we have latest generation machinery and a technical team dedicated to R&D&I to find effective solutions
First steps
1930
  • Tintes Orient S.A is founded in Sant Andreu de Llavaneres. Dyeing of stockings and socks.
1956
  • Relocation of the headquarters to Mataró. Dyeing and bleaching of knitted fabrics
1972
  • Relocation of the headquarters to Hostalric
1975
  • Inauguration of own water treatment plant
Transformation and internationalitation
1999
  • Start-up of Laminats Orient S.L. Acquisition of the first textile coating machine.
2003
  • Opening of the international market with new agents and new products
Looking to the future
2010
  • OEKO-TEX 1000 Eco Friendly company certification
2013
  • Acquisition of a new doctor blade coating machine to respond to new market needs
2014
  • New warehouse
2015
  • New Hotmelt machine with a usable width of 240 cm.
  • Purchase of a new calender machine with a maximum width of 340cm.
  • Tintes Orient and Laminats Orient obtain the Step certificate by Oeko Tex
2016
  • Expansion of the second warehouse.
  • Acquisition of a system for the application of products with exceptional added value for technical fabrics, which makes it possible to give different properties to each side of the fabric.
2017
  • Orient launches its first line of stain-resistant table linen coated with acrylic resin.
2020
  • Debido a la pandemia, lanzamos el primer acabado antiviral con partículas de plata.
  • Due to the Covid pandemic we launched the first antiviral finish with silver particles. Readapting during the pandemic to supply hospital fabrics and becoming an essential company
2021
  • Launch of new brand CB-20 of Antiviric textiles, eco friendly finsh.
  • Grant of the CB-20 patent.
  • CB-20was awarded a european grant of INNO4-COV19 for being one of the 10 best Anti-covid projects in Europe.